OBJECTIVES: To examine the household economic consequences that are associated with out-of-pocket spending for the care and management of chronic obstructive pulmonary disease (COPD). METHODS: A cross-sectional study. A self-administered questionnaire was posted to all patients enrolled (n = 656) in the Respiratory Ambulatory Care Service in western Sydney, Australia, between 1 January 2001 and 31 August 2008. Two hundred and eighteen completed questionnaires were received. RESULTS: One hundred and sixty-nine (78%) respondents experienced economic hardship while managing their illness. Fifty-nine (27%) reported being unable to pay for medical or dental expenses, 38 (18%) were unable to pay for medication, 59 (27%) were unable to pay rent or mortgage and 40 (19%) were unable to pay utility bills. Respondents experiencing economic hardship paid more out-of-pocket overall (=AUD$544 versus =AUD$280; t(148) = -2.03, P = 0.04) and for medications and oxygen specifically (=AUD$247 versus =AUD$125; t(83) = -3.98, P < 0.0001). Fifty-six (46%) respondents had catastrophic levels of out-of-pocket spending which made them 7.5 times more likely to experience economic hardship (95% confidence interval [CI]: 1.2-46.3). CONCLUSIONS: The costs associated with living with COPD make it difficult for patients and their families to afford necessary living expenses while also paying health care expenses. This is alarming within Australia where a well-funded universal health insurance system is in place. Rising co-payments for medications and private medical consultations, poorly subsidised health support (e.g. home oxygen), non-health logistics (e.g. transport) and eligibility barriers for existing social support are making chronic illness management seriously economically stressful, especially for those with low incomes, including the retired.
OBJECTIVES: To examine the household economic consequences that are associated with out-of-pocket spending for the care and management of chronic obstructive pulmonary disease (COPD). METHODS: A cross-sectional study. A self-administered questionnaire was posted to all patients enrolled (n = 656) in the Respiratory Ambulatory Care Service in western Sydney, Australia, between 1 January 2001 and 31 August 2008. Two hundred and eighteen completed questionnaires were received. RESULTS: One hundred and sixty-nine (78%) respondents experienced economic hardship while managing their illness. Fifty-nine (27%) reported being unable to pay for medical or dental expenses, 38 (18%) were unable to pay for medication, 59 (27%) were unable to pay rent or mortgage and 40 (19%) were unable to pay utility bills. Respondents experiencing economic hardship paid more out-of-pocket overall (=AUD$544 versus =AUD$280; t(148) = -2.03, P = 0.04) and for medications and oxygen specifically (=AUD$247 versus =AUD$125; t(83) = -3.98, P < 0.0001). Fifty-six (46%) respondents had catastrophic levels of out-of-pocket spending which made them 7.5 times more likely to experience economic hardship (95% confidence interval [CI]: 1.2-46.3). CONCLUSIONS: The costs associated with living with COPD make it difficult for patients and their families to afford necessary living expenses while also paying health care expenses. This is alarming within Australia where a well-funded universal health insurance system is in place. Rising co-payments for medications and private medical consultations, poorly subsidised health support (e.g. home oxygen), non-health logistics (e.g. transport) and eligibility barriers for existing social support are making chronic illness management seriously economically stressful, especially for those with low incomes, including the retired.
Authors: Lingsheng Li; Judith E Nelson; Laura C Hanson; Christopher E Cox; Shannon S Carson; Emily J Chai; Kristine L Keller; James A Tulsky; Marion Danis Journal: Crit Care Med Date: 2018-05 Impact factor: 7.598
Authors: Michael R Law; Lucy Cheng; Ashra Kolhatkar; Laurie J Goldsmith; Steven G Morgan; Anne M Holbrook; Irfan A Dhalla Journal: CMAJ Open Date: 2018-02-05
Authors: Ashra Kolhatkar; Lucy Cheng; Steven G Morgan; Laurie J Goldsmith; Irfan A Dhalla; Anne M Holbrook; Michael R Law Journal: CMAJ Open Date: 2018-11-19
Authors: Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Taulant Muka; David Imo; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082
Authors: Beverley M Essue; Maree L Hackett; Andreas Mueller; Nguyen Thi Hanh Duc; Huynh Tan Phuc; Stephen Jan Journal: BMC Ophthalmol Date: 2011-09-12 Impact factor: 2.209